The Food and Drug Administration announced on July 7, 2020, that Mylan Institutional LLC is recalling Daptomycin for Injection due to the presence of particulate matter. The agency issued recall number D-1484-2020 for the Class I voluntary recall.
How to tell if you have it
- Brand: Mylan
- Product: Daptomycin for Injection, 500 mg/vial, Single-Dose Vial
- NDC: 67457-813-50
- Lot #: 7605112
- Expiration Date: 10/2021
- Quantity: 18,480 vials
- Distribution: USA Nationwide
The hazard
The recall addresses the presence of particulate matter in the sterile injection vials. The FDA classified this as a Class I hazard.
Context
GovInfoNow's records show Mylan Institutional LLC has conducted 10 other recalls since Jan. 23, 2015. Other recent recalls include a May 3, 2021 labeling error for Mylan Thiamine HCl Injection and an Aug. 17, 2020 label mix-up risk for Mylan Amiodarone Injection. Similar products have faced issues such as the July 2, 2026 precipitate risk in Mylan Mycophenolate Mofetil Injection and particulate matter hazards in B. Braun Medical's April 28, 2026 Lactated Ringer's Injection recall.